Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 5,000 shares at $353.36 ($1.8M) on 2024-09-04, disclosed to the SEC on 2024-09-05.
Open-market sale of $1.8M UTHR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $360.31 | 700 | $252K | 14.2% |
| 2 | $353.36 | 4,300 | $1.5M | 85.8% |
| Total | $354.33 avg | 5,000 | $1.8M | 100% |
| Filing → |
| UTHR | SELL | 2025-12-16 | $496K | — | Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |